Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors
University of Southern California
University of Southern California
Eli Lilly and Company
Zhejiang Cancer Hospital
Taiho Pharmaceutical Co., Ltd.
Fifth Affiliated Hospital, Sun Yat-Sen University
Seagen Inc.
Jiangsu HengRui Medicine Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
China Medical University Hospital
Xiangya Hospital of Central South University
Masonic Cancer Center, University of Minnesota
Altor BioScience
Chang Gung Memorial Hospital
University of Kentucky
National Cancer Institute (NCI)
Dartmouth-Hitchcock Medical Center